New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.
Coagulation Sciences LLC, a medical device startup that is being incubated at the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has selected Enercon Technologies of Gray, Maine, to be its contract manufacturing partner for its Multiple Coagulation Test SystemTM (MCTS).
The MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging (NIA), one of the institutes of the National Institutes of Health, for research on the cellular mechanisms governing longevity.
Neuroscientist Andrea R. Tilden, Ph.D., is spending her sabbatical year from her position as the J. Warren Merrill Associate Professor of Biology at Colby College in Waterville, Maine, as a visiting scientist in comparative genomics at the MDI Biological Laboratory.
Vicki P. Losick, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine, has been recognized as an “outstanding investigator” by the National Institute of General Medical Sciences, an institute of the National Institutes of Health (NIH), for her research on wound healing.
The answer to regenerative medicine’s most compelling question — why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot — may lie with the body’s innate immune system, according to a new study of heart regeneration in the axolotl, or Mexican salamander, an org…
The Maine Technology Institute (MTI) has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an est…
Novo Biosciences Inc., a spinoff of the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of MSI-1436 as a potential regenerative medicine therapy for th…
The MDI Biological Laboratory has announced that Sam Beck, Ph.D., has joined the faculty as an assistant professor of computational biology. Beck, 37, will lead a research team focused on the study of progeria, or Hutchinson-Gilford progeria syndrome, a rare, fatal, genetic condition characterized by accelerated aging in children.
Pharmaceutical developers are under increasing pressure to deliver high-value products that are affordable to patients and society. But the costs of bringing new drugs to market are significant. What’s involved in bringing a new drug to market and what is considered when valuing these new therapies? Former pharmaceutical company executive Josephine A. Sollano, DrPH, will discuss this timely topic at a Science Café entitled “Demystifying the Valuation of Pharmaceutical Innovations” to be…